Thanks for sharing that NBB....

That story from Aug 2015 is probably as good an example as any for explaining why I have such a jaded view of the public markets.  It helps that AQXP trades on the Nasdaq in the U.S. and not OTC.  

In July 2015 AQXP was trading up around $7/$8 and then it crashed under $2...Sound familar?  Kinda of like RVX post assure.  But as that story reported the shares closed on that Tuesday August 11th at $21....and with a CNN mention this little company suddenly got massive exposure to the investing public, the sheep....the herd.

I bet you there were thousands of people searching google and doing research on AQX-1125.  And no doubt plenty of people decided to risk some money in the day and days following that story, investing at $20, $17, $15 per share.

Today those shares are worth less than $11 and haven't once gone back over $20.  

So let's see what the share structure looked like before and after that big (but very short lived) spike that got the minions at CNN to profile this obscure litte Canadian Biotech.

According to their filings as of August 5th 2015 there were 10,727,221 shares outstanding.  By November 9th of 2015 that number had grown to 17,211,986 shares.  A year later on November 9th 2016 that number had grown to 23,423,150 which is about where it is now.

That's the way the industry works too often in my opinion.  A stock climbs 1,000% AND THEN the media takes notice and gives some obscure company massive exposure. 

So why does Resverlogix have such a hard time getting media time and/or column inches?  Is the story not compelling enough?  Nope, not in my view.  The reason why we're still so far under the radar is because there are always AQXP type situations out there.  Companies who need retail investors buying the shares they're printing.  And the CNNs/CNBCs/BNNs etc of the world, they're there to bring the retail sheep in from the field to the shearing house, that's my view.

I don't like it but its reality.  There's no magic slide rule for determining what RVX could be worth, no alchemical forumla that can be applied to arrive at a number, its all spit balling.  The only time that changes is if there's a buyout.  If a BP player comes along and says "we'll give you $5 billion USD for all the outstanding shares", then it is simple math...that $5 billion figure divided by the number of shares determines the price.  And if approved the trading range would become very tight around that price...like a nickel above and below until the deal closes.

$2 per share?  $5? $20?  $100?  IMO you can justify all those prices.